Best Practice & Research Clinical Rheumatology
Volume 24, Issue 1 , Pages 51-70, February 2010

Targeting subchondral bone for treating osteoarthritis: what is the evidence?

  • Steeve Kwan Tat, PhD (Post-doctoral student, University of Montreal)
  • ,
  • Daniel Lajeunesse, PhD (Professor of Medicine, Director of Biomedical Sciences, University of Montreal)
  • ,
  • Jean-Pierre Pelletier, MD (Professor of Medicine, University of Montreal; Head, Arthritis Centre, University of Montreal; Director, Osteoarthritis Research Institute)
  • ,
  • Johanne Martel-Pelletier, PhD (Professor of Medicine, University of Montreal; Director, Osteoarthritis Research Institute)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 514 890 8000x26658; fax: +1 514 412 7582.

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, 1560 Sherbrooke Street East, Montreal, Quebec H2L 4M1, Canada

Over the past few decades, significant progress has been made with respect to new concepts about the pathogenesis of osteoarthritis (OA). This article summarises some of the knowledge we have today on the involvement of the subchondral bone in OA. It provides substantial evidence that changes in the metabolism of the subchondral bone are an integral part of the OA disease process and that these alterations are not merely secondary manifestations, but are part of a more active component of the disease. Thus, a strong rationale exists for therapeutic approaches that target subchondral bone resorption and/or formation, and data evaluating the drugs targeting bone remodelling raise the hope that new treatment options for OA may become available.

Keywords: subchondral bone, osteoarthritis, articular tissues

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(09)00087-4

doi:10.1016/j.berh.2009.08.004

Best Practice & Research Clinical Rheumatology
Volume 24, Issue 1 , Pages 51-70, February 2010